Skip to main content
. 2021 Oct 18;8:715953. doi: 10.3389/fcvm.2021.715953

Table 3.

Variables associated with strain in the patient group; univariate and multivariable analyses.

Univariate analysisb Multivariable analysisc
Variable N Mean ± SD or β (SE) P Adjusted mean (SE) or β (SE) P
Age (years) 90 −0.086 (0.058) 0.143 0.043 (0.094) 0.646
Sex (m/f) 0.031* 0.020*
Male 41 21.46 ± 2.59 21.89 (0.75)
Female 49 20.21 ± 2.78 20.56 (0.72)
BMI, kg/m2 90 −0.151 (0.071) 0.036* −0.215 (0.068) 0.002*
Follow-up time (years) 90 −0.106 (0.048) 0.029* −0.199 (0.088) 0.027*
Cardiac risk group 0.491 0.222
No risk 5 21.68 ± 2.48 23.83 (1.83)
Low 4 19.70 ± 3.39 20.48 (1.41)
Intermediate 47 21.08 ± 2.94 20.94 (0.51)
High 34 20.37 ± 2.46 19.64 (0.64)
Cumulative anthracycline dose,a mg/m2 90 −0.001 (0.003) 0.727 0.002 (0.005) 0.619
Chest radiotherapy 0.004* 0.370
No 70 21.22 ± 2.50 21.57 (0.59)
Yes 20 19.26 ± 3.11 20.87 (0.93)
Hypertension 0.291 0.527
Normal 63 20.96 ± 2.91 21.43 (0.70)
High 26 20.27 ± 2.33 21.03 (0.78)
*

Indicates statistically significant.

β indicates regression coefficient for one-unit increase in continuous variables.

a

Doxorubicin isotoxic equivalents.

b

The means between two groups were compared with the independent samples t-test and between cardiac risk groups with the one-way ANOVA.

Linear regression was used to evaluate the association of continuous variable with strain.

c

Multivariable linear model.